Australian Clinical Labs
ACL.AX
#6796
Rank
ยฃ0.36 B
Marketcap
ยฃ1.83
Share price
1.73%
Change (1 day)
37.28%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2023: ยฃ0.09413

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is ยฃ0.09413. In 2023 the company made an earnings per share (EPS) of ยฃ0.09413 a decrease over its 2022 EPS that were of ยฃ0.48.

EPS history for Australian Clinical Labs from 2021 to 2023

Annual EPS

Year EPS Change
2023ยฃ0.09413-80.55%
2022ยฃ0.48104.3%
2021ยฃ0.24